An arrangement agreed between the supplier of a PBS-listed medicine and the Australian Government that adequately monitors identified risks (or undesired events such as cost-ineffective use or greater-than-expected use) and manages them by appropriate mechanisms for sharing the impact of these risks between the supplier and the government should they arise. CoA
Risk Sharing Arrangement
by Patient Voice Initiative | Sep 3, 2019 | Glossary, R